Biodegradable endoprostheses and methods of their fabrication

US9259339B1 · US · B1

Patent metadata
FieldValue
Publication numberUS-9259339-B1
Application numberUS-201514682014-A
CountryUS
Kind codeB1
Filing dateApr 8, 2015
Priority dateAug 15, 2014
Publication dateFeb 16, 2016
Grant dateFeb 16, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A biodegradable stent prosthesis formed from a degradable polymeric material, having a plurality of luminal, abluminal, and side surfaces, where at least some of the abluminal surfaces are concave and optionally the side surfaces are convex.

First claim

Opening claim text (preview).

What is claimed is: 1. An expandable biodegradable stent prosthesis comprising: a biodegradable polymeric material which has been formed as a tubular body and patterned into a stent prosthesis comprising struts and crowns having luminal and abluminal surfaces; at least some of the struts and/or crowns cross sections have a convex shaped surface extending between the luminal and abluminal surfaces and at least some of the abluminal surfaces are concave across substantially the width of said surfaces; and wherein said stent prosthesis at body temperature is expandable from a crimped configuration to an expanded larger configuration, and having sufficient strength in the expanded configuration to support a body lumen. 2. An expandable biodegradable stent prosthesis comprising: a biodegradable polymeric material which has been formed as a tubular body and patterned into a stent radially expandable at body temperature from a crimped configuration to a deployed larger configuration, wherein the stent comprises a plurality of struts joined by crowns, wherein said struts and crowns each have a luminal surface, an abluminal surface, and two surfaces extending between the luminal and abluminal surfaces; and wherein at least some of the struts and/or crowns have a convex shape across substantially the thickness of said struts and/or crowns surfaces providing a dogbone shape extending between the luminal and abluminal surfaces; said stent prosthesis in the deployed configuration has sufficient strength to support a body lumen. 3. An expandable biodegradable stent prosthesis comprising: a biodegradable polymeric material which has been formed as a tubular body and patterned into a stent radially expandable at body temperature from a crimped configuration to a deployed larger configuration, wherein the stent comprises a plurality of struts joined by crowns, wherein said struts and crowns each have a luminal surface, an abluminal surface, and two surfaces extending between the luminal and abluminal surfaces; and wherein the cross section of at least some of the struts and/or crowns have a convex shape across substantially the thickness of said struts and/or crowns surfaces and the intersections between the convex surface with the abluminal and luminal surfaces provide a thickness which is the greatest thickness of said struts and/or crowns; said stent prosthesis in the deployed configuration has sufficient strength to support a body lumen. 4. The expandable stent prosthesis of claim 1 , 2 , or 3 , wherein the stent prosthesis body comprises a plurality of expandable rings, each ring is composed of struts joined by crowns, and each ring is connected to an adjacent ring by at least one link. 5. The expandable stent prosthesis of claim 4 , wherein the prosthesis is expandable from a crimped diameter to a deployed diameter at body temperature without substantial rotation of the struts, crowns or links about their axis. 6. The expandable prosthesis of claim 1 , wherein at least some of the struts and/or crowns cross sections have a dogbone shape. 7. The expandable stent prosthesis of claim 6 or 2 , wherein said dog bone shape is not symmetrical. 8. The expandable prosthesis of claim 1 , wherein the biodegradable polymeric material of said expandable stent prosthesis comprises at least two biodegradable polymers. 9. The expandable prosthesis of claim 1 , wherein said surfaces have been treated to form the convex and concave surfaces. 10. The expandable stent prosthesis of claim 9 , wherein the treatment includes laser shaping or shaping by application of a solvent by at least one of dipping, spraying, or contact with a solvent vapor. 11. The expandable stent prosthesis of claim 9 , wherein the treatment includes shaping by tumbling, agitating, deburring, scraping, media blasting, laser treatment or heat treatment. 12. The expandable stent prosthesis of claim 9 , wherein a mass of the expandable stent prosthesis after treatment is substantially the same as before treatment. 13. The expandable stent prosthesis of claim 9 , wherein said prosthesis has been treated to redistribute material from the surface of some struts and/or crowns to an immediately adjacent surface of a strut and/or crown without a substantial change in body mass of said expandable stent prosthesis. 14. The expandable stent prosthesis of claim 9 , said prosthesis has been treated to adjust a thickness of the struts and/or crowns from a first thickness before treatment to a second thickness after treatment, wherein the second thickness is greater than the first thickness. 15. The expandable stent prosthesis of claim 9 , wherein the treatment causes a thickness of the struts and/or crowns between the luminal and abluminal surfaces to increase while a width of the struts and/or crowns between the convex surfaces remains substantially the same. 16. The expandable stent of claim 9 , wherein the treatment comprises exposing the expandable prosthesis to a solvent for a predetermined period of time to provide substantially at least some convex surfaces between the luminal and abluminal surfaces and at least some concave abluminal surfaces of said struts and/or crowns. 17. The expandable stent prosthesis of claim 9 , wherein the treatment causes a thickness of the plurality of struts and/or crowns between the luminal and abluminal surfaces to increase while decreasing a minimum width of the struts and/or crowns between the surfaces extending between the luminal and abluminal surfaces by redistributing the polymeric material. 18. The expandable prosthesis of claim 1 , wherein the expandable stent prosthesis body has been patterned by a laser from a continuous tube substantially free from holes or other discontinuities. 19. The expandable stent prosthesis of claim 1 , wherein the expandable stent prosthesis has been patterned from a tube by a laser and wherein the struts and/or crowns have been treated to form said concave abluminal surfaces and convex surfaces extending between the luminal and abluminal surfaces. 20. The expandable stent prosthesis of claim 1 , further comprising a coating of at least one drug and at least one polymer formed over at least some portions of the expandable stent prosthesis body. 21. The expandable stent prosthesis of claim 1 , further comprising a coating over the expandable stent prosthesis, said abluminal surfaces of said struts and/or crowns remaining substantially concave, and said surfaces extending between the luminal and abluminal surfaces of said struts and/or crowns remaining substantially convex. 22. The expandable prosthesis of claim 1 , wherein the biodegradable polymeric material has an elastic modulus of at least 0.35 GPa. 23. The expandable stent prosthesis of claim 1 , 2 , or 3 wherein the biodegradable polymeric material comprises one or more of polymers and copolymers. 24. The expandable stent prosthesis of claim 1 , 2 or 3 wherein the prosthesis is balloon expandable from a crimped diameter to a deployed diameter at body temperature without fracture. 25. The expandable stent prosthesis of claim 1 , 2 or 3 wherein the biodegradable polymeric material comprises at least one material selected from the group consisting of lactides, poly-DL-Lactide, polylactide-co-gycolide, polylactide-co-polycaprolactone, poly (L-lactide-co-trimethylene carbonate), polytrimethylene carbonate, polyhydroxybutyrate, polyhydroxyvalerate, poly orthoesters, po

Assignees

Inventors

Classifications

  • A61F2/89Primary

    the wire-like elements comprising two or more adjacent rings flexibly connected by separate members · CPC title

  • bioabsorbable · CPC title

  • cylindrical · CPC title

  • connected peak to peak · CPC title

  • Metals or alloys · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9259339B1 cover?
A biodegradable stent prosthesis formed from a degradable polymeric material, having a plurality of luminal, abluminal, and side surfaces, where at least some of the abluminal surfaces are concave and optionally the side surfaces are convex.
Who is the assignee on this patent?
Elixir Medical Corp
What technology area does this patent fall under?
Primary CPC classification A61F2/89. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).